Access to Breast Cancer Diagnosis Act of 2021

Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

DDD DingellSponsor

48 cosponsors · 37 D, 11 R

CAD Allred TCR Cole BFR Fitzpatrick DWD Wasserman Schultz LDD Doggett LMD McBath APD Pressley FLR Lucas AKD Kim ELD Luria DSD Soto SWD Wild BVR Van Duyne JND Neguse JCD Cooper NBD Barragán LBD Blunt Rochester LFD Fletcher JMD Morelle RHR Hudson DKD Kilmer MMR Mullin GKD Butterfield PAD Aguilar YKR Kim CHD Houlahan RGD Grijalva DTD Trone MJD Jones SCD Cohen MND Newman TMD Malinowski GCD Connolly ACD Craig JVR Van Drew AKD Kirkpatrick JRD Raskin DTD Titus GMD Moore TMR Mann RKD Kelly MDD Dean GMD Meng MBR Burgess MBR Bost SPD Peters JAD Auchincloss KKD Kahele

4 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

This bill prohibits private health insurance plans from imposing higher cost-sharing requirements on breast cancer diagnostic examinations than initial breast cancer screening examinations. Diagnostic examinations are generally required after an initial screening detects an abnormality and typically require additional mammogram images (e.g., x-rays).